直肠癌病人CD68+ TAMs水平及与CEA联合检测评估复发风险的价值

    Level of CD68+TAMs in rectal cancer patients and value of its combination detection with CEA in evaluating the risk of recurrence

    • 摘要: 目的: 探讨直肠癌根治术病人术前CD68+肿瘤相关巨噬细胞(TAMs)水平及与癌胚抗原(CEA)联合检测评估复发风险的价值。方法: 选取直肠癌根治术治疗病人150例,使用流式细胞术检测癌组织中CD68+ TAMs的表达水平,使用化学发光免疫分析法检测血清CEA水平。对所有病人进行至少1年随访,复发者纳入复发组,未复发者纳入未复发组。比较肿瘤组织和癌旁组织、复发组肿瘤组织与未复发组肿瘤组织中的CD68+ TAMs比例,并使用ROC曲线分析CD68+ TAMs比例和CEA水平联合评估直肠癌根治术病人术后复发风险的约登指数。结果: 病人肿瘤组织中CD68+ TAMs比例为(21.58±3.98)%,高于癌旁正常组织中(8.32±1.06)%(P<0.01)。复发组病人肿瘤组织中CD68+ TAMs比例为(16.25±2.06)%,低于未复发组病人肿瘤组织中(26.85±3.51)%(P<0.01)。单因素分析发现,复发组与未复发组病人CA199、CEA、肿瘤组织CD68+ TAMs比例、病理分型方面差异均有统计学意义(P<0.05~P<0.01)。多因素回归分析显示,血清CEA、病理分型是直肠癌术后病人复发的危险因素(P<0.01和P<0.05),肿瘤组织CD68+ TAMs比例是直肠癌术后病人复发的保护因素(P<0.05)。ROC曲线分析显示,CD68+ TAMs比例与CEA水平联合检测的约登指数高于单独检测。结论: CD68+ TAMs细胞比例在直肠癌组织中较正常组织明显上升。直肠癌根治术后癌组织中CD68+ TAMs比例与术后复发相关,将该指标与术后血清CEA指标联合进行ROC曲线分析,对预测病人复发风险具有一定价值。对于术后癌组织CD68+ TAMs比例和血清CEA水平超过诊断阈值的病人,应警惕复发,可考虑术后强化化疗方案。

       

      Abstract: Objective: To explore the value of preoperative CD68+ tumor-associated macrophages (TAMs) levels and its combination detection with carcinoembryonic antigen (CEA) in evaluating the risk of recurrence in patients undergoing radical resection of rectal cancer. Methods: A total of 150 patients with rectal cancer undergoing radical surgery were selected,the expression level of CD68+ TAMs in cancer tissue was detected using flow cytometry,and serum CEA levels were measured using chemiluminescence immunoassay.All patients were followed up for at least 1 year,who experienced recurrence were included in the recurrence group,and who did not experience recurrence were included in the non-recurrence group.The proportion of CD68+TAMs in tumor tissue and adjacent cancer tissue,as well as in tumor tissue of the recurrence group and non-recurrence group were compared.The receiver operating characteristic (ROC) curve was used to analyze the combined evaluation of CD68+ TAMs proportion level and CEA level to evaluate the Jordan index of postoperative recurrence risk in rectal cancer patients undergoing radical surgery. Results: The proportion of CD68+ TAMs in tumor tissue of 150 patients was (21.58±3.98)%,while the proportion of CD68+ TAMs in normal tissue adjacent to cancer was (8.32±1.06)%,and the difference of which between the two groups was statistically significant (P<0.01).The proportion of CD68+ TAMs in tumor tissue of patients in the recurrence group was (16.25±2.06)%,while the proportion of CD68+ TAMs in tumor tissue of patients in the non-recurrence group was (26.85±3.51)%,and the difference of which between the two groups was statistically significant (P<0.01).Univariate analysis indicated that there were significant differences in CA199,CEA,proportion of CD68+ TAMs in tumor tissue,and pathological classification between the recurrence group and non-recurrence group (P<0.05 to P<0.01).Multivariate regression analysis showed that serum CEA and pathological classification were risk factors for postoperative recurrence in rectal cancer patients (P<0.01 and P<0.05),while the proportion of CD68+ TAMs in tumor tissue was a protective factor for postoperative recurrence in rectal cancer patients (P<0.05).ROC curve analysis showed that the Jordan index of the combined detection of CD68+ TAMs ratio and CEA level was higher than that of individual detection. Conclusions: The proportion of CD68+ TAMs is significantly increased in rectal cancer tissues compared to normal tissues.The proportion of CD68+TAMs in postoperative rectal cancer tissues is correlated with postoperative recurrence.Combining this indicator with postoperative serum CEA for ROC curve analysis has certain value in predicting the risk of recurrence in patients.For patients with postoperative cancer tissue CD68+ TAMs ratio and serum CEA levels exceeding the diagnostic threshold,they should be alert to recurrence and may consider an intensified chemotherapy regimen after surgery.

       

    /

    返回文章
    返回